Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. JNJ
JNJ logo

JNJ

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

JNJ News

Deutsche Bank Sees AtaiBeckley as a Leader in Psychedelic Renaissance

1d agoCNBC

Johnson & Johnson's ICOTYDE Shows Significant Improvement in Psoriasis with New Data

1d agoNASDAQ.COM

Iran War Effects Widen, Pressuring Stock Markets

1d agoCNBC

Impact of Iran War on Global Economies

1d agoYahoo Finance

Johnson & Johnson Reports New Data on ICOTYDE Skin Clearance Rates

1d agoNewsfilter

Johnson & Johnson Reports ICOTYDE Skin Clearance Data

1d agoYahoo Finance

J&J: One-Year Results of ICOTYDE™ (ICOTROKINRA) Show Sustained Skin Clearance and Positive Safety Profile for Once-Daily Pill in Treating Plaque Psoriasis

1d agomoomoo

Eli Lilly Faces Competitive Pressure but Maintains Optimistic Outlook

2d agoFool

Eli Lilly's Competitive Margin Analysis

2d agoNASDAQ.COM

Intuitive Surgical Faces Challenges and Opportunities Ahead

2d agoFool

Long-Term Investment Potential in Strong Healthcare Stocks

2d agoFool

Market Dynamics and Investment Opportunities Analysis

2d agoCNBC

DARZALEX Approved for Self-Administration in Europe

3d agoNASDAQ.COM

A Guide for Managing Market Uncertainty in Q2 2026

3d agoMarketbeat

Meta Faces Legal Challenges, Stock Drops 8%

3d agoCNBC

Market Outlook Dims as Analysts Downgrade Key Stocks

3d agoCNBC